Design, Synthesis, and Biological Evaluation of Novel 1,3,4-Thiadiazole Derivatives as Potential Antitumor Agents against Chronic Myelogenous Leukemia: Striking Effect of Nitrothiazole Moiety

Molecules. 2017 Dec 27;23(1):59. doi: 10.3390/molecules23010059.

Abstract

In an attempt to develop potent antitumor agents, new 1,3,4-thiadiazole derivatives were synthesized and evaluated for their cytotoxic effects on multiple human cancer cell lines, including the K562 chronic myelogenous leukemia cell line that expresses the Bcr-Abl tyrosine kinase. N-(5-Nitrothiazol-2-yl)-2-((5-((4-(trifluoromethyl)phenyl)amino)-1,3,4-thiadiazol-2-yl)thio)acetamide (2) inhibited the Abl protein kinase with an IC50 value of 7.4 µM and showed selective activity against the Bcr-Abl positive K562 cell line. Furthermore, a Bcr-Abl-compound 2 molecular modelling simulation highlighted the anchoring role of the nitrothiazole moiety in bonding and hydrophobic interaction with the key amino acid residues. These results provide promising starting points for further development of novel kinase inhibitors.

Keywords: Bcr-Abl; benzothiazole; kinase inhibitor; leukemia; thiadiazole; thiazole.

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Binding Sites
  • Cell Line, Tumor
  • Cell Survival
  • Drug Screening Assays, Antitumor / methods
  • Fusion Proteins, bcr-abl / antagonists & inhibitors
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Inhibitory Concentration 50
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Magnetic Resonance Spectroscopy / methods
  • Models, Molecular
  • Protein Binding
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Thiadiazoles / chemical synthesis*
  • Thiadiazoles / chemistry
  • Thiadiazoles / pharmacology

Substances

  • Antineoplastic Agents
  • Thiadiazoles
  • 1,3,4-thiadiazole
  • Fusion Proteins, bcr-abl